A genetic association study of the FXYD domain containing ion transport regulator 6 (FXYD6) gene, encoding phosphohippolin, in susceptibility to schizophrenia in a Japanese population

Neuroscience Letters

Volumn 438, Issue 1, 2008, Pages 70-75

  Ito, Yoshihito ^a   Nakamura, Yukako ^a   Takahashi, Nagahide ^a,d   Saito, Shinichi ^a   Aleksic, Branko ^a,b   Iwata, Nakao ^b   Inada, Toshiya ^c   Ozaki, Norio ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c SEIWA HOSPITAL   (Japan)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Association study; FXYD6; Linkage disequilibrium; Schizophrenia; Single nucleotide polymorphism

Indexed keywords

DYSADHERIN; ION CHANNEL; PHOSPHODIESTERASE I; PHOSPHOHIPPOLIN;

ARTICLE; CONTROLLED STUDY; DNA FLANKING REGION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC CODE; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN DOMAIN; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL;

ADULT; AGED; BRAIN; BRAIN CHEMISTRY; CATIONS; CHROMOSOME MAPPING; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HUMANS; ION CHANNELS; JAPAN; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN STRUCTURE, TERTIARY; SCHIZOPHRENIA; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 43549093266     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.04.010     Document Type: Article

References (28)

1. Balding D.J. A tutorial on statistical methods for population association studies. Nat. Rev. 7 (2006) 781-791
2. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
3. Braff D.L., Freedman R., Schork N.J., and Gottesman I.I. Deconstructing schizophrenia: an overview of the use of endophenotypes in order to understand a complex disorder. Schizophrenia Bull. 33 (2007) 21-32
4. Chakravarti A. Population genetics-making sense out of sequence. Nat. Genet. 21 (1999) 56-60
5. Choudhury K., McQuillin A., Puri V., Pimm J., Datta S., Thirumalai S., Krasucki R., Lawrence J., Bass N.J., Quested D., Crombie C., Fraser G., Walker N., Nadeem H., Johnson S., Curtis D., St Clair D., and Gurling H.M. A genetic association study of chromosome 11q22-24 in two different samples implicates the FXYD6 Gene, encoding phosphohippolin, in susceptibility to schizophrenia. Am. J. Hum. Genet. 80 (2007) 664-672
6. Craddock N., O'Donovan M.C., and Owen M.J. Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophrenia Bull. 32 (2006) 9-16
7. de Bakker P.I., Yelensky R., Pe'er I., Gabriel S.B., Daly M.J., and Altshuler D. Efficiency and power in genetic association studies. Nat. Genet. 37 (2005) 1217-1223
8. Delprat B., Schaer D., Roy S., Wang J., Puel J.L., and Geering K. FXYD6 is a novel regulator of Na,K-ATPase expressed in the inner ear. J. Biol. Chem. 282 (2007) 7450-7456
9. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet. Epidemiol. 25 (2003) 115-121
10. Harrison P.J., and Owen M.J. Genes for schizophrenia? Recent findings and their pathophysiological implications. Lancet 361 (2003) 417-419
11. Kadowaki K., Sugimoto K., Yamaguchi F., Song T., Watanabe Y., Singh K., and Tokuda M. Phosphohippolin expression in the rat central nervous system. Brain Res. Mol. Brain Res. 125 (2004) 105-112
12. Lewis C.M., Levinson D.F., Wise L.H., DeLisi L.E., Straub R.E., Hovatta I., Williams N.M., Schwab S.G., Pulver A.E., Faraone S.V., Brzustowicz L.M., Kaufmann C.A., Garver D.L., Gurling H.M., Lindholm E., Coon H., Moises H.W., Byerley W., Shaw S.H., Mesen A., Sherrington R., O'Neill F.A., Walsh D., Kendler K.S., Ekelund J., Paunio T., Lonnqvist J., Peltonen L., O'Donovan M.C., Owen M.J., Wildenauer D.B., Maier W., Nestadt G., Blouin J.L., Antonarakis S.E., Mowry B.J., Silverman J.M., Crowe R.R., Cloninger C.R., Tsuang M.T., Malaspina D., Harkavy-Friedman J.M., Svrakic D.M., Bassett A.S., Holcomb J., Kalsi G., McQuillin A., Brynjolfson J., Sigmundsson T., Petursson H., Jazin E., Zoega T., and Helgason T. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: schizophrenia. Am. J. Hum. Genet. 73 (2003) 34-48
13. Lewis D.A., and Levitt P. Schizophrenia as a disorder of neurodevelopment. Annu. Rev. Neurosci. 25 (2002) 409-432
14. Maziade M., Raymond V., Cliche D., Fournier J.P., Caron C., Garneau Y., Nicole L., Marcotte P., Couture C., and Simard C. Linkage results on 11Q21-22 in Eastern Quebec pedigrees densely affected by schizophrenia. Am. J. Med. Genet. 60 (1995) 522-528
15. +-dependent glutamate transport. J. Biomed. Sci. 12 (2005) 975-984
16. Nanko S., Gill M., Owen M., Takazawa N., Moridaira J., and Kazamatsuri H. Linkage study of schizophrenia with markers on chromosome 11 in two Japanese pedigrees. Jpn. J. Psychiatry Neurol. 46 (1992) 155-159
17. Neale B.M., and Sham P.C. The future of association studies: gene-based analysis and replication. Am. J. Hum. Genet. 75 (2004) 353-362
18. Nyholt D.R. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am. J. Hum. Genet. 74 (2004) 765-769
19. Purcell S., Cherny S.S., and Sham P.C. Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19 (2003) 149-150
20. Rapoport J.L., Addington A.M., Frangou S., and Psych M.R. The neurodevelopmental model of schizophrenia: update 2005. Mol. Psychiatry 10 (2005) 434-449
21. Ross C.A., Margolis R.L., Reading S.A., Pletnikov M., and Coyle J.T. Neurobiology of schizophrenia. Neuron 52 (2006) 139-153
22. Schwab S.G., Knapp M., Mondabon S., Hallmayer J., Borrmann-Hassenbach M., Albus M., Lerer B., Rietschel M., Trixler M., Maier W., and Wildenauer D.B. Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am. J. Human Genet. 72 (2003) 185-190
23. Shifman S., Bronstein M., Sternfeld M., Pisante-Shalom A., Lev-Lehman E., Weizman A., Reznik I., Spivak B., Grisaru N., Karp L., Schiffer R., Kotler M., Strous R.D., Swartz-Vanetik M., Knobler H.Y., Shinar E., Beckmann J.S., Yakir B., Risch N., Zak N.B., and Darvasi A. A highly significant association between a COMT haplotype and schizophrenia. Am. J. Human Genet. 71 (2002) 1296-1302
24. Shigeri Y., Seal R.P., and Shimamoto K. Molecular pharmacology of glutamate transporters, EAATs and VGLUTs. Brain Res. Brain Res. Rev. 45 (2004) 250-265
25. Sweadner K.J., and Rael E. The FXYD gene family of small ion transport regulators or channels: cDNA sequence, protein signature sequence, and expression. Genomics 68 (2000) 41-56
26. Turner J.A., Smyth P., Macciardi F., Fallon J.H., Kennedy J.L., and Potkin S.G. Imaging phenotypes and genotypes in schizophrenia. Neuroinformatics 4 (2006) 21-49
27. Williams N.M., Green E.K., Macgregor S., Dwyer S., Norton N., Williams H., Raybould R., Grozeva D., Hamshere M., Zammit S., Jones L., Cardno A., Kirov G., Jones I., O'Donovan M.C., Owen M.J., and Craddock N. Variation at the DAOA/G30 locus influences susceptibility to major mood episodes but not psychosis in schizophrenia and bipolar disorder. Arch. Gen. Psychiatry 63 (2006) 366-373
28. Yamaguchi F., Yamaguchi K., Tai Y., Sugimoto K., and Tokuda M. Molecular cloning and characterization of a novel phospholemman-like protein from rat hippocampus. Brain Res. Mol. Brain Res. 86 (2001) 189-192